annual shareholders equity:
$228.54M+$34.02M(+17.49%)Summary
- As of today (August 4, 2025), APLS annual stockholders equity is $228.54 million, with the most recent change of +$34.02 million (+17.49%) on December 31, 2024.
- During the last 3 years, APLS annual shareholders equity has risen by +$29.88 million (+15.04%).
- APLS annual shareholders equity is now at all-time high.
Performance
APLS Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$156.31M-$7.91M(-4.82%)Summary
- As of today (August 4, 2025), APLS quarterly stockholders equity is $156.31 million, with the most recent change of -$7.91 million (-4.82%) on June 30, 2025.
- Over the past year, APLS quarterly shareholders equity has dropped by -$108.02 million (-40.87%).
- APLS quarterly shareholders equity is now -66.18% below its all-time high of $462.24 million, reached on March 31, 2022.
Performance
APLS quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
APLS Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.5% | -40.9% |
| 3 y3 years | +15.0% | -53.3% |
| 5 y5 years | +567.7% | -32.6% |
APLS Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.5% | -62.1% | at low |
| 5 y | 5-year | at high | +567.7% | -66.2% | +210.5% |
| alltime | all time | at high | +4953.4% | -66.2% | +210.5% |
APLS Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $156.31M(-4.8%) |
| Mar 2025 | - | $164.22M(-28.1%) |
| Dec 2024 | $228.54M(+17.5%) | $228.54M(-3.6%) |
| Sep 2024 | - | $237.12M(-10.3%) |
| Jun 2024 | - | $264.33M(-0.9%) |
| Mar 2024 | - | $266.68M(+37.1%) |
| Dec 2023 | $194.52M(+14.5%) | $194.52M(-16.3%) |
| Sep 2023 | - | $232.27M(-32.8%) |
| Jun 2023 | - | $345.40M(-16.2%) |
| Mar 2023 | - | $412.12M(+142.6%) |
| Dec 2022 | $169.87M(-14.5%) | $169.87M(-44.7%) |
| Sep 2022 | - | $307.42M(-8.1%) |
| Jun 2022 | - | $334.42M(-27.7%) |
| Mar 2022 | - | $462.24M(+132.7%) |
| Dec 2021 | $198.66M(-2.9%) | $198.66M(-446.6%) |
| Sep 2021 | - | -$57.33M(-59.5%) |
| Jun 2021 | - | -$141.49M(-373.9%) |
| Mar 2021 | - | $51.66M(-74.7%) |
| Dec 2020 | $204.56M | $204.56M(+93.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $105.84M(-54.4%) |
| Jun 2020 | - | $232.06M(-10.4%) |
| Mar 2020 | - | $259.00M(+656.7%) |
| Dec 2019 | $34.23M(-78.7%) | $34.23M(-75.5%) |
| Sep 2019 | - | $139.56M(-12.3%) |
| Jun 2019 | - | $159.09M(-29.2%) |
| Mar 2019 | - | $224.75M(+39.6%) |
| Dec 2018 | $160.97M(+8.1%) | $160.97M(-17.9%) |
| Sep 2018 | - | $195.95M(-14.6%) |
| Jun 2018 | - | $229.55M(+77.9%) |
| Mar 2018 | - | $129.04M(-13.4%) |
| Dec 2017 | $148.94M(+526.0%) | $148.94M(+1120.5%) |
| Sep 2017 | - | $12.20M(-49.2%) |
| Jun 2017 | - | $24.00M(+0.9%) |
| Dec 2016 | $23.79M(-32.0%) | $23.79M(-32.0%) |
| Dec 2015 | $34.98M(+164.5%) | $34.98M(+215.5%) |
| Sep 2015 | - | $11.09M(-28.7%) |
| Jun 2015 | - | $15.55M(+17.6%) |
| Dec 2014 | $13.22M(+192.4%) | $13.22M |
| Dec 2013 | $4.52M | - |
FAQ
- What is Apellis Pharmaceuticals, Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
- What is Apellis Pharmaceuticals, Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?
What is Apellis Pharmaceuticals, Inc. annual stockholders equity?
The current annual shareholders equity of APLS is $228.54M
What is the all time high annual shareholders equity for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high annual stockholders equity is $228.54M
What is Apellis Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
Over the past year, APLS annual stockholders equity has changed by +$34.02M (+17.49%)
What is Apellis Pharmaceuticals, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of APLS is $156.31M
What is the all time high quarterly shareholders equity for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high quarterly stockholders equity is $462.24M
What is Apellis Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?
Over the past year, APLS quarterly stockholders equity has changed by -$108.02M (-40.87%)